Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain.
Heterogeneity of oligodendrocyte progenitor cells in adult human brain.
Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.
Severe Autoimmune Adverse Events Post Herpes Zoster Vaccine: A Case-Control Study of Adverse Events in a National Database.
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
Self-intermittent catheterization in multiple sclerosis.
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Never-resting microglia: physiological roles in the healthy brain and pathological implications.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
[Neurology at the border of centuries: achievements and prospects].
Biomechanical disorders of foot in multiple sclerosis.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
Therapeutic Yoga: Symptom Management for Multiple Sclerosis.
The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
Epigenetics in NG2 glia cells.
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
Neuroborreliosis during natalizumab treatment in multiple sclerosis.
Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor.

Pages